- Home
- / Accent Therapeutics
Accent Therapeutics
Total Funding
$103 M
Accent Therapeutics Summary
Company Summary
- Overview
- Accent Therapeutics is a biopharmaceutical company engaged in the development of therapies for cancer. It focuses on the design of potent drug molecules that selectively inhibit RNA-modifying proteins (RMPs) driving cancer.
- Type
- Private
- Status
- Active
- Founded
- 2017
- HQ
- Lexington, MA, US | view all locations
- Website
- https://www.accenttx.com/
- Cybersecurity rating
Table of Contents
Key People
Robert A. Copeland, President, Co-Founder, Chief Scientific Officer
Kenneth Duncan, Vice President Chemistry
Nicole Heifner, Chief Financial Officer
